Brian K Jefferson
Overview
Explore the profile of Brian K Jefferson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
351
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alexandrou M, Rempakos A, Mutlu D, Al Ogaili A, Carvalho P, Strepkos D, et al.
J Invasive Cardiol
. 2024 Aug;
37(1).
PMID: 39121079
No abstract available.
2.
Alexandrou M, Rempakos A, Mutlu D, Al Ogaili A, Choi J, Poommipanit P, et al.
J Invasive Cardiol
. 2024 May;
36(9).
PMID: 38776473
Background: There is variability in clinical and lesion characteristics as well as techniques in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Methods: We analyzed patient and lesion characteristics, techniques,...
3.
Alexandrou M, Mutlu D, Rempakos A, Al Ogaili A, Choi J, Poommipanit P, et al.
J Invasive Cardiol
. 2024 May;
36(10).
PMID: 38691399
Ranolazine is an anti-anginal medication given to patients with chronic angina and persistent symptoms despite medical therapy. We examined 11 491 chronic total occlusion (CTO) percutaneous coronary interventions (PCI) that...
4.
Yeh R, Shlofmitz R, Moses J, Bachinsky W, Dohad S, Rudick S, et al.
JAMA
. 2024 Mar;
331(12):1015-1024.
PMID: 38460161
Importance: Drug-coated balloons offer a potentially beneficial treatment strategy for the management of coronary in-stent restenosis. However, none have been previously evaluated or approved for use in coronary circulation in...
5.
Alexandrou M, Rempakos A, Mutlu D, Al Ogaili A, Choi J, Poommipanit P, et al.
J Invasive Cardiol
. 2024 Feb;
36(4).
PMID: 38412445
Background: There is limited data on equipment loss or entrapment during chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Methods: We analyzed the baseline clinical and angiographic characteristics and outcomes...
6.
Kostantinis S, Rempakos A, Simsek B, Karacsonyi J, Allana S, Alaswad K, et al.
J Invasive Cardiol
. 2023 Nov;
35(9).
PMID: 37983108
Background: There is limited information on the impact of the target vessel on the procedural techniques and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Methods: We analyzed...
7.
OGrady N, Alexander E, Alhazzani W, Alshamsi F, Cuellar-Rodriguez J, Jefferson B, et al.
Crit Care Med
. 2023 Oct;
51(11):1570-1586.
PMID: 37902340
Rationale: Fever is frequently an early indicator of infection and often requires rigorous diagnostic evaluation. Objectives: This is an update of the 2008 Infectious Diseases Society of America and Society...
8.
OGrady N, Alexander E, Alhazzani W, Alshamsi F, Cuellar-Rodriguez J, Jefferson B, et al.
Crit Care Med
. 2023 Oct;
51(11):1566-1569.
PMID: 37902339
No abstract available.
9.
Simsek B, Rempakos A, Kostantinis S, Karacsonyi J, Gorgulu S, Alaswad K, et al.
Circ Cardiovasc Interv
. 2023 Jun;
16(6):e012977.
PMID: 37259859
Background: Death is a rare but devastating complication of chronic total occlusion (CTO) percutaneous coronary intervention. Methods: We examined the clinical characteristics and procedural outcomes of patients who died periprocedurally...
10.
Simsek B, Khatri J, Young L, Kostantinis S, Karacsonyi J, Rempakos A, et al.
Catheter Cardiovasc Interv
. 2023 Mar;
101(6):1028-1035.
PMID: 36960766
Background: Same day discharge (SDD) following chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has received limited study. Methods: We evaluated the clinical, angiographic, and procedural characteristics of patients discharged...